-+ 0.00%
-+ 0.00%
-+ 0.00%

INFLARX: SUBSEQUENT POST-HOC ANALYSES SUGGEST POSITIVE TREND IN FAVOR OF VILOBELIMAB, WITH SIGNALS INDICATING POTENTIALLY CONSISTENT TREATMENT EFFECT

路透·12/30/2025 12:30:01

登录查看新闻详情